However, despite its popularity as a quick fix for unwanted fat cells, the lack of scientific backing and absence of FDA approval mean that caution is warranted
Amongst these GLP-1 agonists, Ozempic is the most popular, making up approximately 37.8% of the GLP-1 agonist market with sales of around $22.3 billion in 2025
From my perspective as another manufacturer in the skincare industry, Bo International represents a strong example of a modern contract manufacturing partner that combines ingredient expertise, global production capacity, and full-service private label support
[DOI] [PubMed] [Google Scholar] 70.Meeran K, OShea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, et al
69 BoucherEPlazyCRichardMLSuauAManginICornetMet al
Research comparing oral and injectable semaglutide has found that patients on the oral formulation discontinue treatment at notably higher rates due to gastrointestinal side effects